United States
AstraZeneca Unveils $50 Billion U.S. Investment, Including Major Manufacturing Facility in Virginia
AstraZeneca; investment; United States; Virginia plant; manufacturing; R&D; tariffs; chronic diseases; job creation; pharmaceuticals
FDA Flags Eye Safety Concerns as GSK Seeks Blenrep’s US Return
GSK; Blenrep; FDA; eye safety; ocular toxicity; advisory committee; multiple myeloma; drug approval; United States; relapsed/refractory multiple myeloma
Sanofi Commits $20 Billion to U.S. R&D and Manufacturing by 2030
Sanofi; $20 billion investment; U.S. manufacturing; R&D; job creation; drug launches; domestic partnerships
Roche injects $550M into Indianapolis hub to scale up CGM production
Indianapolis, Roche (company), Continuous glucose monitoring, production, Manufacture, Investments, United States
Roche could rethink $50B US expansion plan if new policies ‘harm’ operations
Roche (company), United States, Investments, expansion, Policy, Infantile Neuroaxonal Dystrophy
Trump signs sweeping executive order to cut US drug prices by ‘up to 90%’
Prices, HHS, United States, Transplant Registry Unified Management Program, Policy
Gilead tees up $11B in new US manufacturing, R&D investments
United States, Investments, Manufacture, R&D, Billion, U.S.
Amid Trumps Trade War, Some Drugmakers Stockpile Products in U.S.
United States, Import, trade deficit
Trump, FDA zero in on foreign factories to give domestic sites an edge
United States Food and Drug Administration, United States, Transplant Registry Unified Management Program, foreign factories, manufacturers
Merck & Co. breaks ground on $1B future US home of Keytruda
United States, Keytruda, Home environment, Merck, Wilmington, Biological Factors